FibroBiologics, Inc. (FBLG)
2025-06-30 | ||||
|---|---|---|---|---|
| Other income | - | |||
| Interest expense | - | |||
| Change in fair value of warrant liability | - | |||
| Commitment fee expenses | - | |||
| Net income (loss) | -4,658,000 | |||
| Net income (loss) attributable to common stockholders | -4,658,000 | |||
| Net loss per common share attributable to common stockholders, basic | -0.12 | |||
| Net loss per share, diluted | -0.12 | |||
| Weighted-average shares outstanding, basic | 38,635,264 | |||
| Weighted-average shares outstanding, diluted | 38,635,264 | |||